XML 19 R6.htm IDEA: XBRL DOCUMENT v3.19.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ 71,368 $ 85,671
Adjustments to reconcile net loss to net cash used in operating activities:    
Total 3,639 11,601
Noncash licensing expense 100 4,000
Depreciation 46 41
Amortization of premium on investment securities (149) (9)
Amortization of debt issuance costs 308 0
Non-cash change in lease liability and right-of-use asset 902 0
Change in fair value of notes payable and accrued interest 78 82
Change in fair value of notes payable and accrued interest (78) (82)
Changes in assets and liabilities:    
Decrease (increase) in prepaid research and development and other current assets 663 (1,213)
Decrease in leasehold interest (91) (53)
(Increase) decrease in accrued interest receivable (10) (22)
(Decrease) increase in accounts payable and accrued expenses (5,588) 8,898
Decrease in lease liability (678) 0
Increase in interest payable 443 0
Increase in other current liabilities 2,388 0
Increase in deferred rent 0 46
Decrease in deferred revenue (76) (76)
Net cash used in operating activities (69,211) (62,226)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchases of equipment (32) (58)
Investment in held-to-maturity securities (14,146) (6,965)
Proceeds from maturity of short-term securities 13,500 14,400
Net cash (used in) provided by investing activities (678) 7,377
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from sale of common stock, net 55,965 104,453
Proceeds from debt financings 29,679 0
Financing costs paid (480) 0
Net cash provided by financing activities 85,164 104,453
NET INCREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH 15,275 49,604
CASH, CASH EQUIVALENTS AND RESTRICTED CASH AT BEGINNING OF PERIOD 43,199 57,305
CASH, CASH EQUIVALENTS AND RESTRICTED CASH AT END OF PERIOD 58,474 106,909
Reconciliation to amounts on consolidated balance sheets:    
Total cash, cash equivalents and restricted cash 43,199 57,305
NONCASH TRANSACTIONS    
Accrued offering costs 60 0
Deferred financing costs 988 $ 0
Warrants issued with debt financing $ 993  
Shares issued in connection with in-licensing agreements 100